Larvol Delta - Blue-Earth-Therapeutics-Announces-Promising-Results-of-Preclinical-Evaluation-of-225AcrhPSMA101-for-Potential-Targeted-Alpha-Therapy-of-Prostate-Cancer

255Ac-rhPSMA-10.1 - Bracco

https://www.businesswire.com/news/home/20230911149493/en/Blue-Earth-Therapeutics-Announces-Promising-Results-of-Preclinical-Evaluation-of-225Ac-rhPSMA-10.1-for-Potential-Targeted-Alpha-Therapy-of-Prostate-Cancer

Sep 11, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next